Bill’s cursing as he rings the closing gong

People desperately clinging to youth the world over were disappointed yesterday when Bill Ackman’s Pershing Square Holdings fund IPO flopped in its first day of trading on the Amsterdam stock exchange.  Ackman had been hoping for a strong showing to add credibility and cash to his joint effort with Allergan (Ticker: AGN) to take over Valeant Pharmaceuticals (Ticker: VRX), maker of the fountain of youth serum, Botox.

Ackman, the billionaire activist investor and guardian of good looks, has grand plans for Botox should he eventually gain control of the coveted toxin.

Continue reading →